	Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary Analysis of the INSPIRE Cluster Randomized Trials. JAMA Netw Open Gohil SK, Avery TR, Kleinman K, Septimus E, Mauricio A, Sands KE, Varma N, Sljivo S, Roemer K, Cooper WS, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith-Sells KN, Hayden MK, Kubiak DW, Burks C, Platt R, Huang SS, Baker MA. PMID: 42268612 [PubMed - in process]
	Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer. JAMA Netw Open Watling CZ, Zhao L, Zhang X, Deubler E, Gonzalez-Feliciano AG, Graubard BI, Petrick JL, Wojt A, Butera G, Hofmann JN, Beane Freeman LE, Shrubsole MJ, Zheng W, Sudenga SL, Schernhammer E, Eliassen AH, Mucci LA, Sesso HD, Sinha R, Loftfield E, Um CY, McCullough ML, Jenab M, Zhang X, McGlynn KA. PMID: 42268607 [PubMed - in process]
	Change in Adherence to Oral Antidiabetic Medications Before and After Prostate Cancer Diagnosis: A Group-Based Trajectory Modeling Approach. Clin Drug Investig Kenawy AS, Baffoe JO, Park C. PMID: 42268571 [PubMed - as supplied by publisher]
	The impact of the PI3K/AKT/mTOR signaling pathway on trastuzumab resistance in HER2-positive gastric cancer. Clin Transl Oncol Salehi A, Piccaluga PP. PMID: 42268566 [PubMed - as supplied by publisher]
	Association of PD-L1 combined positive score with disease control and response kinetics with first-line pembrolizumab-based therapy in metastatic triple-negative breast cancer: results from routine clinical practice in Poland. Clin Transl Oncol Pieni, , Konieczna A, Danielewicz I, Winsko-Szcz, Roman A, , Meluch M, Wronowicz J, Czartoryska-Ar, Jarz, , Püsküllüo. PMID: 42268564 [PubMed - as supplied by publisher]
	Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer. Breast Cancer Iwatani T, Masuda N, Saji S, Yamaguchi T, Kojima Y, Kitada M, Tada H, Iwasa T, Koizumi K, Shigematsu H, Sagara Y, Okuno T, Hasegawa Y, Tokunaga E, Shien T, Toh U, Hasegawa H, Osaka S, Morita S, Yamashita T. PMID: 42268523 [PubMed - as supplied by publisher]
	A prognostic model for breast cancer based on mitochondria-associated endoplasmic reticulum membrane (MAM) signature genes. Discov Oncol Cui J, Wei L, Xu B, Han S, Guo C, Wang X. PMID: 42268522 [PubMed - as supplied by publisher]
	Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity. J Thromb Thrombolysis Becker RC. PMID: 42268506 [PubMed - as supplied by publisher]
	Performance evaluation of deep learning based YOLOv5 and YOLOv8 models for real time breast cancer detection in mammographic images. Discov Oncol Sahoo N, Kar A, Khemchandani V. PMID: 42268482 [PubMed - as supplied by publisher]
	Development and validation of a machine learning-based model for predicting delirium risk in postoperative brain tumor patients in the Intensive Care Unit. J Neurooncol Liu L, Huang S, Huang Y, Xu J. PMID: 42268477 [PubMed - in process]
	Identifying PLAU as a shared pathogenic gene in type 2 diabetes and bladder urothelial carcinoma through integrated transcriptomic analysis and machine learning for diagnostic and therapeutic value. Clin Exp Med Xin S, Li G, Yang X, Su J, Li R, Qin W, Zhang Z, Wang C, Zhu Y, Feng L, Ren S, Gao Z. PMID: 42268472 [PubMed - as supplied by publisher]
	A mixed-method study of identifying symptom clusters in adult patients with advanced cancer. Support Care Cancer Miladinia M, Zarea K, Gheibizadeh M, Jahangiri M, Karimpourian H, Rokhafroz D. PMID: 42268436 [PubMed - in process]
	Nanotechnology integration in oncology for advanced nanoparticle based strategies in targeted cancer diagnosis and treatment. Discov Nano Fahim YA, Hasani IW, Kabba S. PMID: 42268351 [PubMed]
	Biocellulose-Based Functional Materials in Cancer Research: Advances in Biosensing, Diagnostics, and Therapy: A Comprehensive Review. Appl Biochem Biotechnol Alhujaily M, Tayeb FJ, Felemban MF, Shafie A. PMID: 42268344 [PubMed - as supplied by publisher]
	TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial. Clin Cancer Res Xu C, Wang SY, Nie M, Yang KY, Huang XQ, Qu S, Chen H, Shen LF, Huang J, Zhang F, Peng YP, Shi LL, Hong XH, Zhang ZJ, Tang LL, Guo L, Ouyang PY, Gao JM, Mao YP, Huang Y, Guo R, Liu LZ, Tian L, Li HJ, Li JB, Ma J, Xia Y, Cai QQ. PMID: 42268339 [PubMed - as supplied by publisher]
	MRI versus histopathology in EMVI detection for rectal cancer: prognostic relevance and survival outcomes. Eur Radiol Lunder AK, Meltzer S, Frøyen EA, Lyckander LG, Grandal OJ, Ree AH, Redalen KR, Negård A. PMID: 42268308 [PubMed - as supplied by publisher]
	Head-to-head pathologic validation of Node-RADS vs size-based criteria for cervical lymph node metastasis in nasopharyngeal carcinoma. Eur Radiol Huang Y, Wu Z, Huang D, Lin K, Huang Y, Huang Y, Zheng Y, Huang C, Zhong J, Pan J, Lin S, Pan C, Liu N, Guo Q. PMID: 42268307 [PubMed - as supplied by publisher]
	Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer. Cancer Res Main SC, Elliott MJ, Singhawansa A, Zou J, Zeng Y, Cheng N, Yu C, Hilton JF, Awadalla P, He HH, Bedard PL, Lupien M, Bratman SV, Cescon DW. PMID: 42268298 [PubMed - as supplied by publisher]
	The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers predict the risk of colorectal cancer: A case-control study. Cancer Biomark Karami R, Najafi E, Babaei A, Shahdoust E, Shaghaghi A, Amiri-Dashatan N, Motlagh B, Koushki M, Khodabandehloo H. PMID: 42267882 [PubMed - in process]
	Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control. Cancer Rep (Hoboken) Obeagu EI. PMID: 42267720 [PubMed - in process]

Articles 1 - 20 / 1941734

Page 1 of 97087



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy